RM Magazine - spring 2012 - The Royal Marsden
Cancer: Scientists aim to double survival within a decade | The Independent
Potential of immunotherapy in head and neck cancer | VJOncology
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Potential of immunotherapy in head and neck cancer | VJOncology
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Potential of immunotherapy in head and neck cancer | VJOncology
Kevin Harrington (@kevhar6763) / Twitter
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington | Oncologist in Sutton - Doctify
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington | Oncologist in Sutton - Doctify
Professor Kevin Harrington - The Institute of Cancer Research, London
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Kevin Harrington | Oncologist in Sutton - Doctify
Scientific Advisory Board – PsiVac
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Immunotherapy kinder than chemotherapy for pa | EurekAlert!
